These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37108853)

  • 41. Diagnosis of Aspergillosis in Horses.
    Dobiáš R; Jahn P; Tóthová K; Dobešová O; Višňovská D; Patil R; Škríba A; Jaworská P; Škorič M; Podojil L; Kantorová M; Mrázek J; Krejčí E; Stevens DA; Havlíček V
    J Fungi (Basel); 2023 Jan; 9(2):. PubMed ID: 36836276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis-A pilot study.
    Ajayababu A; Singh G; Meena VP; Upadhyay AD; Rana B; Sethi P; Prakash B; Singh A; Vyas S; Sinha S; Xess I; Wig N; Kabra SK; Ray A
    Mycoses; 2024 Jan; 67(1):e13695. PubMed ID: 38282361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections.
    Rose SR; Vallabhajosyula S; Velez MG; Fedorko DP; VanRaden MJ; Gea-Banacloche JC; Lionakis MS
    J Infect; 2014 Sep; 69(3):278-83. PubMed ID: 24797077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superinfections in COVID-19 patients receiving extracorporeal membrane oxygenation support.
    Andersen HV; Jørgensen VRL; Steensen M; Pedersen FM; Helleberg M
    Acta Anaesthesiol Scand; 2023 Jul; 67(6):755-761. PubMed ID: 36906734
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the diagnostic accuracy of galactomannan from the bronchoalveolar lavage fluid of patients with suspected invasive pulmonary aspergillosis.
    Bernardi RM; Holler SR; Almeida EGC; Anton C; Machado FD; Silva DR
    Rev Iberoam Micol; 2022; 39(2):31-35. PubMed ID: 35461766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients.
    Wu Z; Wang L; Tan L; Wu J; Chen Z; Hu M
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115274. PubMed ID: 33453546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
    Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
    Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pervasive but Neglected: A Perspective on COVID-19-Associated Pulmonary Mold Infections Among Mechanically Ventilated COVID-19 Patients.
    Ghazanfari M; Arastehfar A; Davoodi L; Yazdani Charati J; Moazeni M; Abastabar M; Haghani I; Mirzakhani R; Mayahi S; Fang W; Liao W; Nguyen MH; Perlin DS; Hoenigl M; Pan W; Hedayati MT
    Front Med (Lausanne); 2021; 8():649675. PubMed ID: 34195207
    [No Abstract]   [Full Text] [Related]  

  • 51. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
    Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serologic biomarkers in Candida and Aspergillus infections of the central nervous system: A comparison of galactomannan, mannan and β-1,3-D-gucan testing from serum and cerebrospinal fluid.
    Forster J; Hoenigl M; Suerbaum S; Wagener J; Dichtl K
    Mycoses; 2022 Jul; 65(7):709-714. PubMed ID: 35506957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
    Lim SY; Lee YW; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH; Kim SH
    Mycoses; 2021 Sep; 64(9):1124-1131. PubMed ID: 33740824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical value of Aspergillus-specific IgG antibody test in the diagnosis of nonneutropenic invasive pulmonary aspergillosis.
    Lu Y; Liu L; Li H; Chen B; Gu Y; Wang L; Feng C; Chen C; Chen Y; Sun W; Cui X; Cao M; Tao Y; Zhong J; Zhong H; Ni Y; Cai Y; Song M; Liu X; Shi Y; Su X
    Clin Microbiol Infect; 2023 Jun; 29(6):797.e1-797.e7. PubMed ID: 36773771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients.
    Mikulska M; Furfaro E; Dettori S; Giacobbe DR; Magnasco L; Dentone C; Ball L; Russo C; Taramasso L; Vena A; Angelucci E; Pelosi P; Bassetti M
    Mycoses; 2022 Apr; 65(4):411-418. PubMed ID: 35138675
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Performance of the Euroimmun Aspergillus Antigen ELISA for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid.
    Egger M; Penziner S; Dichtl K; Gornicec M; Kriegl L; Krause R; Khong E; Mehta S; Vargas M; Gianella S; Porrachia M; Jenks JD; Venkataraman I; Hoenigl M
    J Clin Microbiol; 2022 Apr; 60(4):e0021522. PubMed ID: 35350844
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic value of galactomannan test in non-immunocompromised critically ill patients with influenza-associated aspergillosis: data from three consecutive influenza seasons.
    Huang L; Zhang Y; Hua L; Zhan Q
    Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1899-1907. PubMed ID: 33837879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracorporeal Membrane Oxygenation for COVID-19-associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study.
    Diaz RA; Graf J; Zambrano JM; Ruiz C; Espinoza JA; Bravo SI; Salazar PA; Bahamondes JC; Castillo LB; Gajardo AIJ; Kursbaum A; Ferreira LL; Valenzuela J; Castillo RE; Pérez-Araos RA; Bravo M; Aquevedo AF; González MG; Pereira R; Ortega L; Santis C; Fernández PA; Cortés V; Cornejo RA
    Am J Respir Crit Care Med; 2021 Jul; 204(1):34-43. PubMed ID: 33823118
    [No Abstract]   [Full Text] [Related]  

  • 60. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
    Çuhadar T; Kalkancı A; Tunçcan Güzel Ö; Yeğin ZA; Özkurt ZN; Köktürk N; Yağcı M
    Mikrobiyol Bul; 2023 Apr; 57(2):274-282. PubMed ID: 37067211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.